- Home
- ADTX vs SBFM Comparison
ADTX vs SBFM Comparison
Compare ADTX & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADTX
- SBFM
- Stock Information
- Founded
- ADTX 2017
- SBFM 2006
- Country
- ADTX United States
- SBFM United States
- Employees
- ADTX N/A
- SBFM N/A
- Industry
- ADTX Biotechnology: Pharmaceutical Preparations
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- ADTX Health Care
- SBFM Health Care
- Exchange
- ADTX Nasdaq
- SBFM Nasdaq
- Market Cap
- ADTX 5.3M
- SBFM 4.6M
- IPO Year
- ADTX 2020
- SBFM N/A
- Fundamental
- Price
- ADTX $1.54
- SBFM $1.51
- Analyst Decision
- ADTX
- SBFM Strong Buy
- Analyst Count
- ADTX 0
- SBFM 1
- Target Price
- ADTX N/A
- SBFM $15.00
- AVG Volume (30 Days)
- ADTX 109.4K
- SBFM 104.9K
- Earning Date
- ADTX 05-15-2025
- SBFM 05-15-2025
- Dividend Yield
- ADTX N/A
- SBFM N/A
- EPS Growth
- ADTX N/A
- SBFM N/A
- EPS
- ADTX N/A
- SBFM N/A
- Revenue
- ADTX $55,323.00
- SBFM $36,234,578.00
- Revenue This Year
- ADTX $15,768.94
- SBFM $192.48
- Revenue Next Year
- ADTX N/A
- SBFM N/A
- P/E Ratio
- ADTX N/A
- SBFM N/A
- Revenue Growth
- ADTX N/A
- SBFM 35.51
- 52 Week Low
- ADTX $1.34
- SBFM $1.17
- 52 Week High
- ADTX $27,200.00
- SBFM $11.39
- Technical
- Relative Strength Index (RSI)
- ADTX 35.55
- SBFM 54.20
- Support Level
- ADTX $1.42
- SBFM $1.37
- Resistance Level
- ADTX $1.63
- SBFM $1.56
- Average True Range (ATR)
- ADTX 0.13
- SBFM 0.08
- MACD
- ADTX 0.13
- SBFM 0.02
- Stochastic Oscillator
- ADTX 40.82
- SBFM 73.68
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.